BIFULCO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 7.103
EU - Europa 2.348
AS - Asia 2.107
SA - Sud America 144
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
Totale 11.724
Nazione #
US - Stati Uniti d'America 7.083
CN - Cina 736
UA - Ucraina 616
SG - Singapore 614
IT - Italia 482
VN - Vietnam 425
RU - Federazione Russa 389
DE - Germania 215
SE - Svezia 207
IE - Irlanda 206
TR - Turchia 174
FI - Finlandia 131
BR - Brasile 129
KR - Corea 90
IN - India 31
CZ - Repubblica Ceca 23
GB - Regno Unito 23
NL - Olanda 15
CA - Canada 12
FR - Francia 11
HK - Hong Kong 9
EU - Europa 7
IL - Israele 6
IQ - Iraq 6
AU - Australia 5
ES - Italia 5
AT - Austria 4
BE - Belgio 4
MX - Messico 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
CH - Svizzera 3
ID - Indonesia 3
PE - Perù 3
UZ - Uzbekistan 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
IR - Iran 2
JM - Giamaica 2
PH - Filippine 2
PL - Polonia 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 11.724
Città #
Ann Arbor 2.160
Chandler 899
Jacksonville 751
Princeton 590
Woodbridge 540
Dong Ket 424
Wilmington 394
Houston 300
Singapore 217
Dublin 206
Nanjing 194
Izmir 170
Ashburn 161
Boardman 137
Andover 132
Pellezzano 118
Beijing 99
Salerno 80
Moscow 67
Nanchang 55
Shenyang 55
Fairfield 54
Munich 49
Hebei 46
Jiaxing 44
Norwalk 42
Mestre 40
Changsha 35
Pune 29
Tianjin 27
Brno 23
Naples 20
Dearborn 19
Düsseldorf 19
Helsinki 19
Jinan 19
Shanghai 19
Dallas 18
San Diego 15
Washington 14
Amsterdam 13
São Paulo 13
Los Angeles 12
Qualiano 12
Redwood City 12
West Jordan 12
Zhengzhou 12
Rome 11
Cambridge 10
Seattle 10
Guangzhou 8
Hong Kong 8
Bari 7
Nürnberg 7
Ottawa 7
Council Bluffs 6
Hangzhou 6
Lanzhou 6
Milan 6
Nuremberg 6
Avellino 5
Falls Church 5
Indiana 5
Wuhan 5
Brasília 4
Brussels 4
Casagiove 4
Chengdu 4
Curitiba 4
Duncan 4
Lappeenranta 4
Madrid 4
Porto Alegre 4
San Nicola la Strada 4
Sarno 4
Settimo Milanese 4
Tappahannock 4
Baghdad 3
Bologna 3
Casalnuovo Di Napoli 3
Catania 3
Ferrandina 3
Fisciano 3
Fuzhou 3
Haikou 3
Hefei 3
Kyiv 3
Marano di Napoli 3
Marília 3
Menlo Park 3
Nantong 3
Napoli 3
Phoenix 3
Quanzhou 3
Serang 3
Stockholm 3
Tashkent 3
Tel Aviv 3
Zurich 3
Altavilla Silentina 2
Totale 8.624
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 232
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 155
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 148
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 141
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 129
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 127
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 125
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 123
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 120
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 115
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 114
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 113
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 112
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 111
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 111
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 111
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 110
Dental care and dentistry practice in the Medieval Medical School of Salerno 110
Brain cancer risk: the weight of obesity 110
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 109
Thyroid adiponcosis: more than an hypothesis 108
The endocannabinoid signaling system in cancer 107
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 106
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 105
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 105
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 103
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 103
Cannabidiol: State of the art and new challenges for therapeutic applications 103
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 101
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 100
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 99
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 97
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 96
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 95
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 91
The right to care and the expectations of society?controversial stem cell therapy in Italy 91
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 90
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 90
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 89
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 89
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 89
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 88
Statins and cancer in gastroenterology: new insight? 88
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 88
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 87
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 84
The basis of the modern medical hygiene in the medieval Medical School of Salerno 83
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 82
Statins and cancer-related mortality: an open question. 82
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 82
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 81
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 80
Statins in neurological disorders: an overview and update 80
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 79
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 79
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 77
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 77
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 76
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 76
Cannabinoids and cancer: pros and cons of an antitumour strategy. 75
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 74
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 74
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 74
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 73
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 73
A new role of anandamide in human sperm: focus on metabolism 73
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 72
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 72
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 71
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 71
What we know and do not know about the cannabinoid receptor 2 (CB2) 71
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 70
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 70
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 69
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 69
Breast adiponcosis: a call for further research 69
A focus on Trotula de' Ruggiero: A pioneer in women's and children's health in history of medicine 69
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 69
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 68
The new task for medical scientists 68
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase. 67
Antibiotics exposure in obesity: an update of a complex relationship 67
Politics and Research: a desirable and essential dialogue 66
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 65
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 65
Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: Killing two birds with one stone 65
The endocannabinoid system and its therapeutic exploitation. 64
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation 64
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. 63
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. 63
Comment on 'When in Rome, reform'. 63
Statins for inflammatory bowel disease: Can off-label drug help it? 63
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin 63
Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. 63
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 62
Risk of diabetes with statins must be monitored in each patient 62
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site. 62
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway. 61
Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder 61
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. 61
Totale 8.816
Categoria #
all - tutte 43.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020241 0 0 0 0 0 0 0 0 0 0 220 21
2020/20211.352 24 119 111 5 146 58 142 6 121 1 147 472
2021/20221.029 6 3 2 14 53 14 3 47 141 145 147 454
2022/20231.870 173 145 14 278 271 382 10 184 262 13 82 56
2023/2024670 68 105 42 30 48 114 14 28 8 35 49 129
2024/20251.439 116 27 106 99 79 184 310 170 269 70 9 0
Totale 12.030